The presence of higher IL-13 and IL-17 serum levels in patients, compared with those of controls, confirms that these markers, found with high specificity, might be involved in the pathogenesis of eRA. The gene discussed is IL17A; the disease is enthesitis-related juvenile idiopathic arthritis.